PREMEDI: Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring

Sponsor
Federico II University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05119868
Collaborator
(none)
276
2
2
40
138
3.4

Study Details

Study Description

Brief Summary

Allergy prevalence is increasing steadily with some describing as the "epidemic of the twenty-first century". Maternal diet during pregnancy has been linked to offspring allergy risk, so it represents a potential target for allergy prevention. The Mediterranean Diet (MD) is considered one of the healthiest dietary models which exerts regulatory effects on immune system, due to the synergistic and interactive combinations of nutrients. We aim to study the effects of MD in pregnancy on the onset of allergic diseases at 2 years of age in the offspring.

Condition or Disease Intervention/Treatment Phase
  • Other: Nutritional intervention based on Mediterranean Diet
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
276 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring: a Multi-center Randomised-controlled Trial (the PREMEDI Project)
Anticipated Study Start Date :
Sep 10, 2022
Anticipated Primary Completion Date :
Jan 10, 2025
Anticipated Study Completion Date :
Jan 10, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1

Group 1 will receive standard obstetrical and gynecological follow-up and nutritional intervention based on Mediterranean Diet provided by certified dietitians

Other: Nutritional intervention based on Mediterranean Diet
A personalized nutritional counseling and a tailored diet, according to Mediterranean dietary pattern, designed on the pre-pregnancy weight, height and trimester of pregnancy provided by certified dietitians.

No Intervention: Group 2

Group 2 will receive standard obstetrical and gynecological follow-up alone

Outcome Measures

Primary Outcome Measures

  1. Occurrence of allergic disorders at 24 months of age in the offspring [24 months from birth]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the occurrence of allergic disorders at 24 months of age in the offspring

Secondary Outcome Measures

  1. Maternal weight gain [From enrollment until delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on maternal weight gain

  2. Pregnancy complications occurrence [From enrollment until delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on pregnancy complications occurrence

  3. Perinatal complications occurrence [Delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on perinatal complications occurrence

  4. Neonatal birth weight [Delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on neonatal growth indices

  5. Body growth in the offspring [During the 24 months of life]

    The evaluation of the effect of Mediterranean Diet during pregnancy on body growth in the offspring

  6. Occurrence of any other chronic disorders in the first 2 years of age in the offspring [During the 24 months of life]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the occurrence of any other chronic disorders in the first 2 years of age in the offspring

  7. Mother's gut microbiome metagenomic features [From enrollment until delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the mother's gut microbiome metagenomic features

  8. Mother's gut microbiome metabolomic features [From enrollment until delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the mother's gut microbiome metabolomic features

  9. Son's gut microbiome metagenomic features [During the 24 months of life]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the son's gut microbiome metagenomic features

  10. Son's gut microbiome metabolomic features [During the 24 months of life]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the son's gut microbiome metabolomic features

  11. Breastfeeding duration [During the 24 months of life]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the breastfeeding duration

  12. Breast milk composition [During the 24 months of life]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the breast milk composition

  13. Epigenetic modulation of genes involved in the regulation of immune system in the offspring [Delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the epigenetic modulation of genes involved in the regulation of immune system in the offspring

  14. Epigenetic modulation of genes involved in the metabolic pathways in the offspring [Delivery]

    The evaluation of the effect of Mediterranean Diet during pregnancy on the epigenetic modulation of genes involved in the metabolic pathways in the offspring

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy women (aged 20-35 years), at first trimester of pregnancy, of at risk for atopy baby
Exclusion Criteria:
  • concomitant presence of infections;

  • concomitant presence of malignancies;

  • concomitant presence of major gastrointestinal malformations;

  • concomitant presence of immunodeficiencies;

  • concomitant presence of autoimmune diseases;

  • concomitant presence of chronic inflammatory bowel diseases;

  • concomitant presence of functional gastrointestinal disorders;

  • concomitant presence of celiac disease;

  • history of abdominal surgery with gastrointestinal resection;

  • concomitant presence of neuropsychiatric disorders;

  • concomitant presence of central nervous system disorders;

  • vegan diet;

  • twin pregnancy;

  • concomitant presence of genetic disorders;

  • concomitant presence of metabolic disorders.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Traslational Medical Science - University of Naples Federico II Naples Italy 80131
2 Department of Traslational Medical Science Naples Italy 80131

Sponsors and Collaborators

  • Federico II University

Investigators

  • Principal Investigator: Roberto Berni Canani, Department of Traslational Medical Science at University of Naples Federico II

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Roberto Berni Canani, MD, PhD, Professor of Pediatrics, Federico II University
ClinicalTrials.gov Identifier:
NCT05119868
Other Study ID Numbers:
  • 283/21
First Posted:
Nov 15, 2021
Last Update Posted:
Jun 7, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2022